Details of the Drug Combinations

General Information of This Drug (ID: DMIRPD8)

Drug Name

Colestipol DMIRPD8

Synonyms

Colestid; Colestipol Hydrochloride; Flavored Colestid

Indication

Disease Entry	ICD 11	Status	REF
Hypercholesterolaemia	5C80.0	Approved	[1]
Hyperlipidemia	5C80.Z	Approved	[1]
Primary hypercholesterolemia	5C80.00	Approved	[2]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

3 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Colestipol + Teriflunomide	DCLCVTQ	Teriflunomide	Teriflunomide Elimination	[3]
Lovastatin + Colestipol	DCM6N9B	Lovastatin	Cardiovascular Diseases	[4]
HKI-272 + Colestipol	DCASAWS	HKI-272	Early Stage HER2+ Breast Cancer	[5]
------------------------------------------------------------------------------------

References

1	Colestipol FDA Label
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3	ClinicalTrials.gov (NCT02263547) Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
4	ClinicalTrials.gov (NCT00000512) Familial Atherosclerosis Treatment Study
5	ClinicalTrials.gov (NCT02400476) An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide